Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib
Status:
Completed
Trial end date:
2018-05-25
Target enrollment:
Participant gender:
Summary
This study is conducted to evaluate effect on QT/QTc Interval after multiple dose of
celecoxib among healthy adult volunteers. It is randomized, open-label, negative and postive
control, and crossover study. Volunteers will be mainly checked up through ECG to find out
changes of QT/QTc interval during the study.
Phase:
Phase 1
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Celecoxib Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination